Latest News of PCVX
Should You Consider Investing in Vaxcyte (PCVX)?
By Yahoo! Finance |
2 weeks ago
Baron Funds released their Q3 2024 investor letter for the Baron Health Care Fund, reporting a 5.81% appreciation in the quarter. Vaxcyte, Inc. was highlighted as a top pick, with a one-month return o...
Vaxcyte, Inc. (PCVX): Among Hedge Funds' Top Biotech Stock Picks
By Yahoo! Finance |
2 months ago
An article discusses the risks and potential returns associated with investing in biotech stocks, focusing on Vaxcyte, Inc. (NASDAQ:PCVX) and its progress in developing anti-bacterial treatments....
Insider Sale: COO Jim Wassil Sells 3,000 Shares of Vaxcyte Inc (PCVX)
By Yahoo! Finance |
4 months ago
Vaxcyte Inc is a biotech company focusing on vaccine development for infectious diseases. Recent insider selling trend indicates $229,020 transaction with no insider buys. Investors can analyze market...